PepGen Inc (PEPG)
13.21
-0.44
(-3.22%)
USD |
NASDAQ |
May 17, 16:00
13.21
0.00 (0.00%)
After-Hours: 20:00
PepGen Price to Book Value: 2.383 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.383 |
| May 16, 2024 | 2.472 |
| May 15, 2024 | 2.503 |
| May 14, 2024 | 2.534 |
| May 13, 2024 | 2.409 |
| May 10, 2024 | 2.537 |
| May 09, 2024 | 2.416 |
| May 08, 2024 | 2.481 |
| May 07, 2024 | 2.528 |
| May 06, 2024 | 2.526 |
| May 03, 2024 | 2.572 |
| May 02, 2024 | 2.624 |
| May 01, 2024 | 2.517 |
| April 30, 2024 | 2.222 |
| April 29, 2024 | 2.114 |
| April 26, 2024 | 2.159 |
| April 25, 2024 | 2.117 |
| April 24, 2024 | 2.141 |
| April 23, 2024 | 2.121 |
| April 22, 2024 | 2.061 |
| April 19, 2024 | 1.906 |
| April 18, 2024 | 2.143 |
| April 17, 2024 | 2.081 |
| April 16, 2024 | 2.278 |
| April 15, 2024 | 2.213 |
| Date | Value |
|---|---|
| April 12, 2024 | 2.352 |
| April 11, 2024 | 2.300 |
| April 10, 2024 | 2.153 |
| April 09, 2024 | 2.197 |
| April 08, 2024 | 2.236 |
| April 05, 2024 | 2.152 |
| April 04, 2024 | 2.097 |
| April 03, 2024 | 1.967 |
| April 02, 2024 | 2.361 |
| April 01, 2024 | 2.620 |
| March 28, 2024 | 4.387 |
| March 27, 2024 | 4.205 |
| March 26, 2024 | 3.918 |
| March 25, 2024 | 3.966 |
| March 22, 2024 | 4.449 |
| March 21, 2024 | 4.414 |
| March 20, 2024 | 4.437 |
| March 19, 2024 | 4.169 |
| March 18, 2024 | 4.073 |
| March 15, 2024 | 4.608 |
| March 14, 2024 | 4.151 |
| March 13, 2024 | 4.103 |
| March 12, 2024 | 4.145 |
| March 11, 2024 | 4.217 |
| March 08, 2024 | 4.249 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5463
Minimum
Sep 21 2022
5.163
Maximum
Mar 04 2024
1.735
Average
1.511
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.469 |
| Vertex Pharmaceuticals Inc | 6.195 |
| Sarepta Therapeutics Inc | 12.92 |
| PTC Therapeutics Inc | -- |
| Regenxbio Inc | 2.016 |
Price to Book Value Related Metrics
| Price | 13.21 |
| Earnings Yield | -24.62% |
| Market Cap | 426.61M |